| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2017 | Circulating MicroRNA-125b Predicts the Presence and Progression of Uremic Vascular Calcification | CHIA-TER CHAO ; Liu Y.-P.; SHENG-FANG SU ; Yeh H.-Y.; Chen H.-Y.; Lee P.-J.; Chen W.-J.; Lee Y.-M.; JENQ-WEN HUANG ; CHIH-KANG CHIANG ; KUAN-YU HUNG ; HUEI-WEN CHEN | Arteriosclerosis, Thrombosis, and Vascular Biology | 42 | 43 | |
| 2012 | DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival | De Carvalho D.; Sharma S.; You J.S.; SHENG-FANG SU ; Taberlay P.C.; Kelly T.K.; Yang X.; Liang G.; Jones P.A. | Cancer Cell | 205 | 194 | |
| 2021 | DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a smoking-associated malignancy index | SU, SHENG-FANG ; Ho, Hao; Li, Jia-Hua; Wu, Ming-Fang; Wang, Hsu-Chieh; Yeh, Hsiang-Yuan; SHUENN-WEN KUO ; HUEI-WEN CHEN ; CHAO-CHI HO ; Li, Ker-Chau | The Journal of clinical investigation | 5 | 4 | |
| 1996 | Excessive myocardial contraction in vasovagal syncope demonstrated by echocardiography during head-up tilt test | MING-TSUNG LEE ; MING-FONG CHEN ; SHENG-FANG SU ; CHIA-LUN CHAO ; Liau, C.-S.; Lee, Y.-T. | Clinical cardiology | 33 | 24 | |
| 2021 | Genome-wide epigenetic landscape of lung adenocarcinoma links HOXB9 DNA methylation to intrinsic EGFR-TKI resistance and heterogeneous responses | SU, SHENG-FANG ; Liu, Chia-Hsin; Cheng, Chiou-Ling; CHAO-CHI HO ; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; HUEI-WEN CHEN ; Chang, Gee-Chen; SUNG-LIANG YU ; Li, Ker-Chau | JCO Precision Oncology | 7 | 6 | |
| 2020 | How Taiwan, a non-WHO member, takes actions in response to COVID-19 | SHENG-FANG SU ; Han Y.-Y. | Journal of Global Health | 17 | 15 | |
| 2020 | Landscape of mitochondria genome and clinical outcomes in stage 1 lung adenocarcinoma | Raghav L.; Chang Y.-H.; Hsu Y.-C.; Li Y.-C.; Chen C.-Y.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Chuang C.-Y.; Lee M.-H.; Wang C.-L.; HUEI-WEN CHEN ; SUNG-LIANG YU ; SHENG-FANG SU ; Yuan S.-S.; Chen J.J.W.; Ho S.-Y.; Li K.-C.; PAN-CHYR YANG ; Chang G.-C.; Chen H.-Y. | Cancers | 7 | 7 | |
| 2021 | The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer | Wu M.-F.; Lin C.-A.; Yuan T.-H.; Yeh H.-Y.; SHENG-FANG SU ; Guo C.-L.; Chang G.-C.; Li K.-C.; CHAO-CHI HO ; HUEI-WEN CHEN | Cancer Immunology, Immunotherapy | 17 | 18 | |
| 2017 | Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity | Tseng C.-C.; Jia B.; Barndt R.; Gu Y.; Chen C.-Y.; Tseng I.-C.; SHENG-FANG SU ; Wang J.-K.; Johnson M.D.; Lin C.-Y. | PLoS ONE | 23 | 24 | |
| 2013 | MiR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer | SHENG-FANG SU ; Chang Y.-W.; Andreu-Vieyra C.; Fang J.Y.; Yang Z.; Han B.; Lee A.S.; Liang G. | Oncogene | 103 | 97 | |
| 2014 | A panel of three markers hyper- And hypomethylated in urine sediments accurately predicts bladder cancer recurrence | SHENG-FANG SU ; De Castro Abreu A.L.; Chihara Y.; Tsai Y.; Andreu-Vieyra C.; Daneshmand S.; Skinner E.C.; Jones P.A.; Siegmund K.D.; Liang G. | Clinical Cancer Research | 65 | 63 | |
| 2008 | Purification from human milk of matriptase complexes with secreted serpins: Mechanism for inhibition of matriptase other than HAI-1 | Tseng I.-C.; Chou F.-P.; SHENG-FANG SU ; Oberst M.; Madayiputhiya N.; MING-SHYUE LEE ; Wang J.-K.; Sloane D.E.; Johnson M.; Lin C.-Y. | American Journal of Physiology - Cell Physiology | 38 | 36 | |
| 2014 | Reprogramming of the human intestinal epigenome by surgical tissue transposition | Lay F.D.; Triche Jr. T.J.; Tsai Y.C.; SHENG-FANG SU ; Martin S.E.; Daneshmand S.; Skinner E.C.; Liang G.; Chihara Y.; Jones P.A. | Genome Research | 14 | 14 | |
| 2021 | Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts | Lee P.-J.; CHAO-CHI HO ; Ho H.; Chen W.-J.; Lin C.-H.; Lai Y.-H.; Juan Y.-C.; Chu W.-C.; Lee J.-H.; SHENG-FANG SU ; Chen H.-Y.; Chen J.J.W.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG ; HUEI-WEN CHEN | Theranostics | 6 | 5 | |
| 2008 | Zymogen activation, inhibition, and ectodomain shedding of matriptase | Lin C.-Y.; Tseng I.-C.; Chou F.-P.; SHENG-FANG SU ; Chen Y.-W.; Johnson M.D.; Dickson R.B. | Frontiers in Bioscience | 66 | 67 | |
